Cargando…
Dutch Outcome in Implantable Cardioverter‐Defibrillator Therapy: Implantable Cardioverter‐Defibrillator–Related Complications in a Contemporary Primary Prevention Cohort
BACKGROUND: One third of primary prevention implantable cardioverter‐defibrillator patients receive appropriate therapy, but all remain at risk of defibrillator complications. Information on these complications in contemporary cohorts is limited. This study assessed complications and their risk fact...
Autores principales: | van Barreveld, Marit, Verstraelen, Tom E., van Dessel, Pascal F. H. M., Boersma, Lucas V. A., Delnoy, Peter Paul H. M., Tuinenburg, Anton E., Theuns, Dominic A. M. J., van der Voort, Pepijn H., Kimman, Geert‐Jan, Buskens, Erik, Zwinderman, Aeilko H., Wilde, Arthur A. M., Dijkgraaf, Marcel G. W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174382/ https://www.ncbi.nlm.nih.gov/pubmed/33787324 http://dx.doi.org/10.1161/JAHA.120.018063 |
Ejemplares similares
-
Dutch outcome in implantable cardioverter-defibrillator therapy (DO-IT): registry design and baseline characteristics of a prospective observational cohort study to predict appropriate indication for implantable cardioverter-defibrillator
por: van Barreveld, M., et al.
Publicado: (2017) -
Development and external validation of prediction models to predict implantable cardioverter-defibrillator efficacy in primary prevention of sudden cardiac death
por: Verstraelen, Tom E, et al.
Publicado: (2021) -
Hospital utilisation and the costs associated with complications of ICD implantation in a contemporary primary prevention cohort
por: van Barreveld, M., et al.
Publicado: (2022) -
Implantable cardioverter-defibrillators /
Publicado: (1994) -
The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)